References
- Bayne E K., Donatelli S A., Sargeant J, Singer I I., Lark M W., Hoernner L A., Weidner J R., Williams H R., Mumford R A., Lohmander L S. Trans Orthop Res Soc 1995; 20: 328
- Flannery C R., Lark M W., Sandy J D. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. J Biol Chem 1992a; 267(2)1008–14
- Flannery C R., Stanescu V, Morgelin M, Boynton R, Gordy J, Sandy J D. Variability in the G3 domain content of bovine aggrecan from cartilage extracts and chondrocyte cultures. Arch Biochem Biophys 1992b; 297(1)52–60
- Flannery C R., Sandy J D. Aggrecan catabolism in cartilage. Studies on the nature of a novel proteinase (aggrecanase) which cleaves the glu373-ala 374 bond of the interglobular domain. Orthop Trans 1993; 17(3)677
- Hardingham T E., Fosang A J. The structure of aggrecan and its turnover in cartilage. J Rheumatol 1995; 22(1)86–90, Suppl 43
- Ilic M Z., Handley C J., Robinson H C., Mok M T. Mechanism of Catabolism of Aggrecan. Arch Biochem Biophys 1992; 294: 115–22
- Koob T J., Hernandez D, Gordy J T., Sandy J D. Aggrecan Metabolism in Bovine Meniscus: Role of Aggrecanase in Normal Development. Trans Orthop Res Soc 1995; 20: 3
- Lark M W., Gordy J T., Weidner J R., Ayala J, Kimura J H., Williams H R., Mumford R A., Flannery C R., Carlson S S., Iwata M, Sandy J D. Cell-mediated catabolism of aggrecan: Evidence that cleavage at the “aggrecanase” site (Glu 373 - Ala 374) is a primary event in proteolysis of the interglobular domain. J Biol Chem 1995; 270: 2550–6
- Lohmander L S., Dahlberg L, Ryd L, Heinegard D. Increased levels of proteoglycan fragments in knee joint fluid after injury. Arth Rheum 1989; 32: 1434–42
- Lohmander L S., Neame P J., Sandy J D. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury and osteoarthritis. Arth Rheum 1993; 36: 1214–22
- Loulakis P, Shrikhande A, Davis G, Maniglia C A. N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1 treated articular cultures. Putatives site(s) of enzymatic cleavage. Biochem J 1992; 284: 589–93
- Plaas A H K, Sandy J D. A cartilage explant system for studies on aggrecan structure, biosynthesis and catabolism in discrete zones of the mammalian growth plate. Matrix 1993; 13: 135–47
- Plaas A H K, Midura R J., Poole A R., Hascall V C. Chondroitin sulfate on human aggrecan. Isolation and characterization of non-reducing terminal components. Trans Orthop Res Soc 1995; 20: 428
- Sandy J D., Neame P J., Boynton R E., Flannery C R. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J Biol Chem 1991; 266(14)8683–5
- Sandy J D., Flannery C R., Neame P J., Lohmander S F. The structure of aggrecan fragments in human osteoarthritic synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the glu 373-ala 374 bond of the interglobular domain J Clin Invest 1992; 89(2)1512–16
- Vilim V, Fosang A J. Proteoglycans isolated from dissociative extracts of differently aged human articular cartilage. Biochem J 1994; 304: 887–94